| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.099 | 0.09 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |